Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy Academic Article uri icon

Overview

MeSH Major

  • Neoplasm Recurrence, Local
  • Prostate-Specific Antigen
  • Prostatectomy
  • Prostatic Neoplasms
  • Seminal Vesicles

abstract

  • SVI does not invariably signal BCR or death from cancer in patients who undergo RP and pelvic lymph node dissection. Fifteen years later, approximately 33% of men with SVI and negative lymph nodes are expected remain free of BCR, and CSS was surprisingly good.

publication date

  • June 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.21895

PubMed ID

  • 16649221

Additional Document Info

start page

  • 2369

end page

  • 75

volume

  • 106

number

  • 11